Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$734M |
| 2 |
Boeing
BA
|
+$493M |
| 3 |
Pfizer
PFE
|
+$478M |
| 4 |
UnitedHealth
UNH
|
+$440M |
| 5 |
Honeywell
HON
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.05B |
| 2 |
Advanced Micro Devices
AMD
|
+$447M |
| 3 |
TSMC
TSM
|
+$441M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 5 |
ExxonMobil
XOM
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.34% |
| 2 | Technology | 16.84% |
| 3 | Consumer Discretionary | 12.66% |
| 4 | Industrials | 10.11% |
| 5 | Consumer Staples | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
WisdomTree International Hedged Quality Dividend Growth Fund
IHDG
$2.21B
| $966K | ﹤0.01% |
+24,500
| New | +$934K |
|
2502
AerCap
AER
$24.2B
| $965K | ﹤0.01% |
+17,163
| New | +$1.03M |
|
|
VLD
2503
DELISTED
Velo3D, Inc.
VLD
| $965K | ﹤0.01% |
12,146
-5,822
| -32% | -$523K |
|
2504
Petco
WOOF
$831M
| $964K | ﹤0.01% |
107,100
-488,300
| -82% | -$5.05M |
|
2505
Hycroft Mining Holding Corp
HYMC
$1.92B
| $963K | ﹤0.01% |
222,780
+76,690
| +52% | +$374K |
|
2506
LivaNova
LIVN
$4.53B
| $963K | ﹤0.01% |
+22,094
| New | +$1.12M |
|
2507
AC Immune
ACIU
$226M
| $962K | ﹤0.01% |
411,079
+6,400
| +2% | +$14.8K |
|
|
CODX
2508
Co-Diagnostics
CODX
$5.45M
| $959K | ﹤0.01% |
21,610
-197
| -0.9% | -$15.8K |
|
2509
Apyx Medical
APYX
$176M
| $954K | ﹤0.01% |
331,095
-37,100
| -10% | -$108K |
|
2510
Bel Fuse Inc Class A
BELFA
$3.12B
| $952K | ﹤0.01% |
26,200
+1,600
| +7% | +$58.3K |
|
2511
Mativ Holdings
MATV
$500M
| $951K | ﹤0.01% |
44,312
-50,700
| -53% | -$1.25M |
|
2512
UTStarcom
UTSI
$23.5M
| $951K | ﹤0.01% |
220,726
-24,436
| -10% | -$106K |
|
2513
ARK Web x.0 ETF
ARKW
$1.68B
| $949K | ﹤0.01% |
+17,700
| New | +$862K |
|
|
NETI
2514
DELISTED
Eneti Inc.
NETI
| $946K | ﹤0.01% |
101,209
-32,149
| -24% | -$321K |
|
2515
Victory Capital Holdings
VCTR
$6.49B
| $945K | ﹤0.01% |
32,300
-61,800
| -66% | -$1.88M |
|
|
TDAY
2516
USA Today Co
TDAY
$1.32B
| $944K | ﹤0.01% |
504,600
+200,400
| +66% | +$469K |
|
2517
Citizens
CIA
$236M
| $941K | ﹤0.01% |
253,694
-1,100
| -0.4% | -$3.04K |
|
2518
RXO
RXO
$3.42B
| $941K | ﹤0.01% |
+47,900
| New | +$919K |
|
|
NOAH
2519
Noah Holdings
NOAH
$584M
| $940K | ﹤0.01% |
56,800
-3,000
| -5% | -$55.6K |
|
2520
Euroseas
ESEA
$553M
| $938K | ﹤0.01% |
62,283
-2,950
| -5% | -$45.7K |
|
2521
Revolution Medicines
RVMD
$38.8B
| $938K | ﹤0.01% |
+43,300
| New | +$1.07M |
|
2522
Rush Street Interactive
RSI
$2.9B
| $936K | ﹤0.01% |
300,901
+101
| +0% | +$388 |
|
2523
Cabaletta Bio
CABA
$439M
| $933K | ﹤0.01% |
112,800
-50,600
| -31% | -$474K |
|
2524
Tarsus Pharmaceuticals
TARS
$2.68B
| $930K | ﹤0.01% |
74,000
+8,400
| +13% | +$123K |
|
2525
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
$1.27B
| $929K | ﹤0.01% |
9,700
+200
| +2% | +$18.8K |
|
Similar funds
Renaissance Technologies's Q1 2023 Portfolio in Review
As of Q1 2023, Renaissance Technologies held 4,600 positions worth $75.4B, up 3.1% from $73.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2023 filing shows 524 new, 1,665 increased, 1,689 reduced and 668 closed positions. Its largest new stake was Honeywell: 1,937,917 shares worth $349M. The largest sale was Apple, an estimated $1.05B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q1 2023 buy was Honeywell: 1,937,917 shares worth $349M.
- Renaissance Technologies added most to First Republic Bank in Q1 2023, an estimated $734M increase.
- Renaissance Technologies's biggest Q1 2023 reduction was Apple, cutting an estimated $1.05B.
- Renaissance Technologies fully exited Advanced Micro Devices in Q1 2023, selling an estimated $447M.
- Renaissance Technologies's ten largest holdings make up 11% of its $75.4B portfolio in Q1 2023.
- Renaissance Technologies opened 524 new positions and closed 668 in Q1 2023.
- Renaissance Technologies's portfolio value rose 3.1% quarter-over-quarter to $75.4B.
Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.